Open Beta
TREN
MetriLume
TREN

US marketsKMTS

SEC-sourced researchBeta

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Company comparison ↗

Data passport

CIK
0001877184
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2025: 59,815,000.0000 USD; April 2026: 95,126,000.0000 USD95.1M USD0 USD0April 2025April 2026
KMTS · Exact amounts and source periods · USD
Period endRevenueFiling date
April 202559,815,000.0000Jul 14, 2026
April 202695,126,000.0000Jul 14, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 202695,126,000.0000-131,612,000.0000-81,703,000.0000358,465,000.000098,807,000.0000Jul 14, 2026
April 202559,815,000.0000-113,814,000.0000-77,608,000.0000295,744,000.000090,338,000.0000Jul 14, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$95.13MApril 2026Jul 14, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$59.82MApril 2025Jul 14, 202610-K
Net incomeNetIncomeLoss-$131.61MApril 2026Jul 14, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$81.7MApril 2026Jul 14, 202610-K
Total assetsAssets$358.47MApril 2026Jul 14, 202610-K
Total liabilitiesLiabilities$98.81MApril 2026Jul 14, 202610-K

New filings

Explore methodology ↗